As site Principle Investigator for the Centre for International Bone Marrow Transplant Research (CIBMTR) group, my interests are focused on co-operative, inter-disciplinary programmes aimed at tackling the varied challenges presented by pediatric oncology and hematology patients.
My background in engineering and current experience as a U.S. Naval Flight Surgeon underlines my interest in human factor analysis and risk management within the practice of medicine. In an effort to reduce risk in health management to its lowest possible level, the naval aviation community's use of the "best practice" process to effectively identify, analyze and eliminate or help control a hazard can successfully be applied to our daily endeavors in medicine and will provide insight and options to our practices.
Overlap chronic GVHD is associated with adverse survival outcomes compared to classic chronic GVHD
Bone Marrow Transplantation
DOI: 10.1038/s41409-024-02245-y
2024
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias
Blood Advances
DOI: 10.1182/bloodadvances.2023010281
2023
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events
Blood
DOI: 10.1182/blood.2023020035
2023
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Blood Advances
Qayed, M. and Watkins, B. and Gillespie, S. and Bratrude, B. and Betz, K. and Choi, S.W. and Davis, J. and Duncan, C. and Giller, R. and Grimley, M. and Harris, A.C. and Jacobsohn, D. and Lalefar, N. and Norkin, M. and Farhadfar, N. and Pulsipher, M.A. and Shenoy, S. and Petrovic, A. and Schultz, K.R. and Yanik, G.A. and Waller, E.K. and Langston, A. and Kean, L.S. and Horan, J.T.
DOI: 10.1182/bloodadvances.2021005208
2022
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Journal of Clinical Oncology
DOI: 10.1200/JCO.20.01086
2021
Ifosfamide, gemcitabine, and vinorelbine is an effective salvage regimen with excellent stem cell mobilization in relapsed or refractory pediatric Hodgkin lymphoma
Pediatric Blood and Cancer
Marr, K. and Ronsley, R. and Nadel, H. and Douglas, K. and Gershony, S. and Strahlendorf, C. and Davis, J.H. and Deyell, R.J.
DOI: 10.1002/pbc.28167
2020
PTPRD copy number variants and Ewing's sarcoma: Strengthening the association and therapeutic implications
Cancer Genetics
DOI: 10.1016/j.cancergen.2019.03.004
2019
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients
Biology of Blood and Marrow Transplantation
Bhatt, S.T. and Bednarski, J.J. and Berg, J. and Trinkaus, K. and Murray, L. and Hayashi, R. and Schulz, G. and Hente, M. and Grimley, M. and Chan, K.W. and Kamani, N. and Jacobsohn, D. and Nieder, M. and Hale, G. and Yu, L. and Adams, R. and Dalal, J. and Pulsipher, M.A. and Haut, P. and Chaudhury, S. and Davis, J. and Jaroscak, J. and Andreansky, M. and Willert, J. and Shenoy, S.
DOI: 10.1016/j.bbmt.2018.10.008
2019
Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression
Biology of Blood and Marrow Transplantation
Jacobsohn, D.A. and Loken, M.R. and Fei, M. and Adams, A. and Brodersen, L.E. and Logan, B.R. and Ahn, K.W. and Shaw, B.E. and Kletzel, M. and Olszewski, M. and Khan, S. and Meshinchi, S. and Keating, A. and Harris, A. and Teira, P. and Duerst, R.E. and Margossian, S.P. and Martin, P.L. and Petrovic, A. and Dvorak, C.C. and Nemecek, E.R. and Boyer, M.W. and Chen, A.R. and Davis, J.H. and Shenoy, S. and Savasan, S. and Hudspeth, M.P. and Adams, R.H. and Lewis, V.A. and Kheradpour, A. and Kasow, K.A. and Gillio, A.P. and Haight, A.E. and Bhatia, M. and Bambach, B.J. and Haines, H.L. and Quigg, T.C. and Greiner, R.J. and Talano, J.-A.M. and Delgado, D.C. and Cheerva, A. and Gowda, M. and Ahuja, S. and Ozkaynak, M. and Mitchell, D. and Schultz, K.R. and Fry, T.J. and Loeb, D.M. and Pulsipher, M.A.
DOI: 10.1016/j.bbmt.2018.06.010
2018
Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes
JCI insight
Wong, J.C. and Bryant, V. and Lamprecht, T. and Ma, J. and Walsh, M. and Schwartz, J. and Del Pilar Alzamora, M. and Mullighan, C.G. and Loh, M.L. and Ribeiro, R. and Downing, J.R. and Carroll, W.L. and Davis, J. and Gold, S. and Rogers, P.C. and Israels, S. and Yanofsky, R. and Shannon, K. and Klco, J.M.
DOI: 10.1172/jci.insight.121086
2018
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
Blood
Haddad, E. and Logan, B.R. and Griffith, L.M. and Buckley, R.H. and Parrott, R.E. and Prockop, S.E. and Small, T.N. and Chaisson, J. and Dvorak, C.C. and Murnane, M. and Kapoor, N. and Abdel-Azim, H. and Hanson, I.C. and Martinez, C. and Bleesing, J.J.H. and Chandra, S. and Smith, A.R. and Cavanaugh, M.E. and Jyonouchi, S. and Sullivan, K.E. and Burroughs, L. and Skoda-Smith, S. and Haight, A.E. and Tumlin, A.G. and Quigg, T.C. and Taylor, C. and Dávila Saldaña, B.J. and Keller, M.D. and Seroogy, C.M. and Desantes, K.B. and Petrovic, A. and Leiding, J.W. and Shyr, D.C. and Decaluwe, H. and Teira, P. and Gillio, A.P. and Knutsen, A.P. and Moore, T.B. and Kletzel, M. and Craddock, J.A. and Aquino, V. and Davis, J.H. and Yu, L.C. and Cuvelier, G.D.E. and Bednarski, J.J. and Goldman, F.D. and Kang, E.M. and Shereck, E. and Porteus, M.H. and Connelly, J.A. and Fleisher, T.A. and Malech, H.L. and Shearer, W.T. and Szabolcs, P. and Thakar, M.S. and Vander Lugt, M.T. and Heimall, J. and Yin, Z. and Pulsipher, M.A. and Pai, S.-Y. and Kohn, D.B. and Puck, J.M. and Cowan, M.J. and O?Reilly, R.J. and Notarangelo, L.D.
DOI: 10.1182/blood-2018-03-840702
2018
Health-Related Quality of Life in Survivors of High-Risk Neuroblastoma After Stem Cell Transplant: A National Population-Based Perspective
Pediatric Blood and Cancer
Portwine, C. and Rae, C. and Davis, J. and Teira, P. and Schechter, T. and Lewis, V. and Mitchell, D. and Wall, D.A. and Pullenayegum, E. and Barr, R.D.
DOI: 10.1002/pbc.26063
2016
Successful clinical treatment and functional immunological normalization of human MALT1 deficiency following hematopoietic stem cell transplantation
Clinical Immunology
Rozmus, J. and McDonald, R. and Fung, S.-Y. and Del Bel, K.L. and Roden, J. and Senger, C. and Schultz, K.R. and McKinnon, M.L. and Davis, J. and Turvey, S.E.
DOI: 10.1016/j.clim.2016.04.011
2016
Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning Is Successful in Children with Hematologic Cytopenias of Genetic Origin
Biology of Blood and Marrow Transplantation
Kothari, A. and Ngwube, A. and Hayashi, R. and Murray, L. and Davis, J. and Haut, P. and Loechelt, B.J. and Shenoy, S.
DOI: 10.1016/j.bbmt.2015.03.019
2015
Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: Outcome by intensity of conditioning
British Journal of Haematology
Veys, P.A. and Nanduri, V. and Baker, K.S. and He, W. and Bandini, G. and Biondi, A. and Dalissier, A. and Davis, J.H. and Eames, G.M. and Egeler, R.M. and Filipovich, A.H. and Fischer, A. and Jürgens, H. and Krance, R. and Lanino, E. and Leung, W.H. and Matthes, S. and Michel, G. and Orchard, P.J. and Pieczonka, A. and Ringdén, O. and Schlegel, P.G. and Sirvent, A. and Vettenranta, K. and Eapen, M.
DOI: 10.1111/bjh.13347
2015
Transplantation outcomes for severe combined immunodeficiency, 2000-2009
New England Journal of Medicine
Pai, S.-Y. and Logan, B.R. and Griffith, L.M. and Buckley, R.H. and Parrott, R.E. and Dvorak, C.C. and Kapoor, N. and Hanson, I.C. and Filipovich, A.H. and Jyonouchi, S. and Sullivan, K.E. and Small, T.N. and Burroughs, L. and Skoda-Smith, S. and Haight, A.E. and Grizzle, A. and Pulsipher, M.A. and Chan, K.W. and Fuleihan, R.L. and Haddad, E. and Loechelt, B. and Aquino, V.M. and Gillio, A. and Davis, J. and Knutsen, A. and Smith, A.R. and Moore, T.B. and Schroeder, M.L. and Goldman, F.D. and Connelly, J.A. and Porteus, M.H. and Xiang, Q. and Shearer, W.T. and Fleisher, T.A. and Kohn, D.B. and Puck, J.M. and Notarangelo, L.D. and Cowan, M.J. and O'Reilly, R.J.
DOI: 10.1056/NEJMoa1401177
2014
Outcomes after Hematopoietic Stem Cell Transplantation for Children with I-Cell Disease
Biology of Blood and Marrow Transplantation
Lund, T.C. and Cathey, S.S. and Miller, W.P. and Eapen, M. and Andreansky, M. and Dvorak, C.C. and Davis, J.H. and Dalal, J.D. and Devine, S.M. and Eames, G.M. and Ferguson, W.S. and Giller, R.H. and He, W. and Kurtzberg, J. and Krance, R. and Katsanis, E. and Lewis, V.A. and Sahdev, I. and Orchard, P.J.
DOI: 10.1016/j.bbmt.2014.06.019
2014
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency
Journal of Allergy and Clinical Immunology
Dvorak, C.C. and Hassan, A. and Slatter, M.A. and Hönig, M. and Lankester, A.C. and Buckley, R.H. and Pulsipher, M.A. and Davis, J.H. and Güngör, T. and Gabriel, M. and Bleesing, J.H. and Bunin, N. and Sedlacek, P. and Connelly, J.A. and Crawford, D.F. and Notarangelo, L.D. and Pai, S.-Y. and Hassid, J. and Veys, P. and Gennery, A.R. and Cowan, M.J.
DOI: 10.1016/j.jaci.2014.06.021
2014
Outcomes of Allogeneic Hematopoietic cell transplantation in patients with Dyskeratosis Congenita
Biology of Blood and Marrow Transplantation
Gadalla, S.M. and Sales-Bonfim, C. and Carreras, J. and Alter, B.P. and Antin, J.H. and Ayas, M. and Bodhi, P. and Davis, J. and Davies, S.M. and Deconinck, E. and Deeg, H.J. and Duerst, R.E. and Fasth, A. and Ghavamzadeh, A. and Giri, N. and Goldman, F.D. and Kolb, E.A. and Krance, R. and Kurtzberg, J. and Leung, W.H. and Srivastava, A. and Or, R. and Richman, C.M. and Rosenberg, P.S. and Toledo Codina, J.S.D. and Shenoy, S. and Socié, G. and Tolar, J. and Williams, K.M. and Eapen, M. and Savage, S.A.
DOI: 10.1016/j.bbmt.2013.05.021
2013
Dexmedetomidine for co-analgesia in chemotherapy-induced severe enterocolitis
Paediatric Anaesthesia
Winton, P. and Whyte, E. and Reimer, E.J. and Davis, J. and Whyte, S.
DOI: 10.1111/j.1460-9592.2011.03575.x
2011
Leukemic transformation of anaplastic large-cell lymphoma
Blood
Vawda, A. and Davis, J. and Vercauteren, S.
DOI: 10.1182/blood-2010-11-318048
2011
Optimizing outcomes of hematopoietic stem cell transplantation for severe combined immunodeficiency
Clinical Immunology
Cuvelier, G.D.E. and Schultz, K.R. and Davis, J. and Hirschfeld, A.F. and Junker, A.K. and Tan, R. and Turvey, S.E.
DOI: 10.1016/j.clim.2009.01.003
2009
Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency
Pediatrics
Qasim, W. and Cavazzana-Calvo, M. and Davies, E.G. and Davis, J. and Duval, M. and Eames, G. and Farinha, N. and Filopovich, A. and Fischer, A. and Friedrich, W. and Gennery, A. and Heilmann, C. and Landais, P. and Horwitz, M. and Porta, F. and Sedlacek, P. and Seger, R. and Slatten, M. and Teague, L. and Eapen, M. and Veys, P.
DOI: 10.1542/peds.2008-1191
2009
Improving patient safety by design - A new spinal/intrathecal injection safety system [4]
Canadian Journal of Anesthesia
Sheppard, I. and Davis, J. and Blackstock, D.
DOI: 10.1007/bf03021540
2006
Detection of a novel nonsense mutation in the interleukin 2 receptor ¿ gene causing X-linked severe combined immunodeficiency [2]
Annals of Allergy, Asthma and Immunology
Cohen, L. and Hirschfeld, A.F. and Junker, A.K. and Davis, J. and Turvey, S.E.
DOI: 10.1016/S1081-1206(10)63563-6
2006
Torticollis as a sign of cervico-thoracic epidural haematoma in an infant with severe haemophilia A
Haemophilia
Cuvelier, G.D.E. and Davis, J.H. and Purves, E.C. and Wu, J.K.
DOI: 10.1111/j.1365-2516.2006.01323.x
2006
Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita
Blood
H. Ly
DOI: 10.1182/blood-2005-01-0247
08/2005
Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: A description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations
Biology of Blood and Marrow Transplantation
Fraser, G.A.M. and Walker, I.I. and Russell, J. and Larratt, L. and Davis, J. and Hogge, D. and Voralia, M. and Rubinger, M. and Schroeder, M. and Walker, I. and Doyle, J. and Messner, H. and Berinstein, N. and Howson-Jan, K. and Lopez, P. and Huebsch, I. and Moquin, J.-P. and Roy, J. and Champagne, M. and Laneuville, P. and Mitchell, D. and Lachance, S. and Cantin, G. and Couture, F. and Couban, S. and Duggan, P.
DOI: 10.1016/j.bbmt.2003.10.007
2004
Second malignancy following high-dose therapy and autologous stem cell transplantation: Incidence and risk factor analysis
Bone Marrow Transplantation
Forrest, D.L. and Nevill, T.J. and Naiman, S.C. and Le, A. and Brockington, D.A. and Barnett, M.J. and Lavoie, J.C. and Nantel, S.H. and Song, K.W. and Shepherd, J.D. and Sutherland, H.J. and Toze, C.L. and Davis, J.H. and Hogge, D.E.
DOI: 10.1038/sj.bmt.1704243
2003
Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy
Medical and Pediatric Oncology
McCahon, E. and Sorensen, P.H.B. and Davis, J.H. and Rogers, P.C.J. and Schultz, K.R.
DOI: 10.1002/mpo.10272
2003
The North American Immune Tolerance Registry: Practices, outcomes, outcome predictors
Thrombosis and Haemostasis
DiMichele, D.M. and Kroner, B.L. and Adair, S. and Addiego, J. and Anderson, V. and Barbosa, J. and Blatt, P. and Bockenstedt, P. and Castle, V. and Chenaille, P. and Cohen, J. and Czapek, E. and Davis, J. and Davignon, G. and De Alarcon, P. and Dubowy, R. and DuCore, J. and Dugdale, M. and Ewenstein, B. and Fahner, J. and Gribble, T.J. and Gnarra, D. and Gruppo, R. and Hakami, N. and Hanna, M. and Hanna, W. and Haut, P. and Heggie, G. and Homans, A. and Hutter, J. and Johnson, C. and Kajani, M. and Karpatkin, M. and Kasper, C. and Katz, J. and Kessler, C. and Key, N. and Koerper, M. and Konkle, B. and Kosinski, R. and Lazerson, J. and Lightsey, A. and Loew, T. and Lusher, J. and MacLaughlin, W. and Manco-Johnson, M. and Manno, C. and McRedmond, K. and Phatak, P. and Powell, J. and Ragni, M. and Rosenfield, C. and Sanders, J. and Santiago-Borrero, P. and Saidi, P. and Seeler, R. and Seremetis, S. and Sexauer, J. and Travis, S. and Valdez, L. and Warner, E. and White, G. and Barrand, D. and Drown, J. and Herst, J. and Inwood, M. and Lillicrap, D. and Rivard, G. and Rubin, S. and Stranczyniski, H. and Teitel, J.
DOI: 10.1055/s-0037-1612943
2002
Candida dubliniensis fungemia and vascular access infection
Journal of Pediatric Hematology/Oncology
Cimolai, N. and Davis, J. and Trombley, C.
DOI: 10.1097/00043426-200203000-00017
2002
Efficacy and safety of the factor VIII/von Willebrand factor concentrate, Haemate-P/Humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease
Thrombosis and Haemostasis
Lillicrap, D. and Poon, M.-C. and Walker, I. and Xie, F. and Schwartz, B.A. and Akabutu, J. and Ali, K. and Barnard, D. and Blanchette, V. and Bond, M. and Carcao, M. and Card, R. and David, M. and Davis, J. and Delorme, M. and Demers, C. and Dolan, S. and Drouin, J. and Garvey, B. and Gill, K. and Growe, G. and Herst, J. and Israels, S. and Lepine-Martin, M. and Luke, K.-H. and McCusker, P. and Pai, M. and Ritchie, B. and Rivard, G. and Robinson, S. and Ross, E. and Rubin, S. and Rubinger, M. and Scully, M.F. and Silva, M. and St.-Louis, J. and Stobart, K. and Teitel, J. and Vickars, L. and Wu, J.
DOI: 10.1055/s-0037-1612977
2002
High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing’s Sarcoma Does Not Improve Prognosis
Journal of Clinical Oncology
Paul A. Meyers and Mark D. Krailo and Marc Ladanyi and Ka-Wah Chan and Scott L. Sailer and Paul S. Dickman and David L. Baker and Jeffrey H. Davis and Robert B. Gerbing and Alfred Grovas and Cynthia E. Herzog and Karen L. Lindsley and Wen Liu-Mares and James B. Nachman and Lance Sieger and Jean Wadman and Richard G. Gorlick
DOI: 10.1200/jco.2001.19.11.2812
06/2001
Diamond-blackfan anemia and cyclosporine therapy revisited
American Journal of Pediatric Hematology/Oncology
Alessandri, A.J. and Rogers, P.C. and Wadsworth, L.D. and Davis, J.H.
DOI: 10.1097/00043426-200003000-00020
2000
Causes of death in Canadians with haemophilia 1980-1995
Haemophilia
Walker, I.R. and Julian, J.A. and Growe, G. and Davis, J. and Vickars, L. and Akabutu, J. and Ritchie, B. and Poon, M.-C. and Wu, J. and Card, R. and Ali, K. and Israels, S. and Rubinger, M. and Stobard, K. and Inwood, M. and McCusker, P. and Walker, I. and Pai, M. and Teitel, J. and Garvey, B. and Blanchette, V. and Giles, A. and Lillicrap, D. and Silva, M. and Drouin, J. and Luke, K.-H. and Gill, K. and Herst, J. and Lepine-Martin, M. and Rivard, G. and Bond, M. and David, M. and St.-Louis, J. and Jobin, F. and Demers, C. and Jardine, L. and Scully, M.-F. and Barnard, D. and Robinson, S. and Rubin, S. and Dolan, S. and Ross, E.
DOI: 10.1046/j.1365-2516.1998.00179.x
1998
Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura
British Journal of Haematology
Hand, J.P. and Lawlor, E.R. and Yong, C.K.K. and Davis, J.H.
DOI: 10.1046/j.1365-2141.1998.00602.x
1998
Letters to the editor: Reply
Journal of Pediatric Hematology/Oncology
Lawlor, E.R. and Anderson, R.A. and Davis, J.H. and Fryer, C.J.H. and Pritchard, S.L. and Rogers, P.C.J. and Wu, J.K. and Schultz, K.R.
1997
Immunosuppressive therapy: A potential alternative to bone marrow transplantation as initial therapy for acquired severe aplastic anemia in childhood?
American Journal of Pediatric Hematology/Oncology
Lawlor, E.R. and Anderson, R.A. and Davis, J.H. and Fryer, C.J.H. and Pritchard, S.L. and Rogers, P.C.J. and Wu, J.K. and Schultz, K.R.
DOI: 10.1097/00043426-199703000-00004
1997
Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions
Journal of Pediatrics
Al-Kharfy, T. and Smyth, J.A. and Wadsworth, L. and Krystal, G. and Fitzgerald, C. and Davis, J. and Milner, R.
DOI: 10.1016/S0022-3476(96)70194-4
1996
Obstructive lung disease in children after allogeneic bone marrow transplantation
Blood
Schultz, K.R. and Green, G.J. and Wensley, D. and Sargent, M.A. and Magee, J.F. and Spinelli, J.J. and Pritchard, S. and Davis, J.H. and Rogers, P.C.J. and Chan, K.W. and Phillips, G.L.
DOI: 10.1182/blood.v84.9.3212.bloodjournal8493212
1994
Infantile choriocarcinoma. Re-examination of a potentially curable entity
Cancer
Belchis, D.A. and Mowry, J. and Davis, J.H.
DOI: 10.1002/1097-0142(19930915)72:63.0.CO;2-G
1993
Treatment of Malignancy with Unmodified Antibody
Pathology and Immunopathology Research
Christopher C. Badger and Claudio Anasetti and Jeff Davis and Irwin D. Bernstein
DOI: 10.1159/000157067
1987
A study of hematopoietic stem cell transplantation (HSCT) in non-malignant disease using a reduced-intensity preparatory regime with campath-H, fludarabine and malphalan
It is hoped that this study will provide evidence that a preparative regimen consisting of a combination of campath-H, fludarabine and malphalan will maximize host immunosuppression without myeloablation, while being well tolerated and sufficient for engraftment of donor hemopoietic cells when minimally mismatched from the recipient or acquired from unrelated sources. It is postulated that this combination will allow for the gradual transition from recipient chimerism to full donor chimerism with minimal early and delayed toxicity to the recipient. The target is children with non-malignant diseases who are benefited by transplantation and for whom myeloablation is not necessary.
Demonstration of human safety & physician acceptance of a unique spinal injection safety system (SISS)
The inadvertent administration of the wrong drug, by the spinal or epidural route, often with catastrophic results, continues to occur in medical practice. Several Canadian and world reports have demonstrated the tragic consequences in all medical fields utilizing spinal therapies, including oncology, anaesthesiology, and obstetrics. Specific recent cases of death as a result of the maladministration of vinca alkaloids into the spine have been reported widely. We have redesigned the spinal needle and system around intrathecal administration of medications and in this study we propose to implement the spinal injection safety system (SISS) in clinical practice. Through evaluating the SISS we will determine its safety attributes for pediatric patients receiving spinal chemotherapy and whether or not it meets the practice expectations of physicians. We also seek to significantly reduce the net risk of patient harm through inadvertent human error during the spinal drug administration procedure as well as be cost-effective in comparison to current practices.
Bruce W Jackson Memorial Award for the Reserve Flight Surgeon of the Year, The Society of United States Naval Flight Surgeons - 2014
Rookie of the Year Attending Award, University of British Columbia Residents - 1992
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
The team, led by researchers from BC Children’s Hospital Research Institute and the University of British Columbia, is the first in Canada to combine these two techniques to identify and test a drug for a young patient's tumour in time for their treatment.
We believe there’s nothing we can’t do with your support. It can take years to turn scientific breakthrough into new interventions and treatments. Funding helps speed the pace of change. When given the resources, we can bring transformative therapies – and hope – out of the laboratory and into the clinic to save and improve children’s lives.